Fortress Biotech: HC Wainwright Raises PT to $17, Reiterates Buy Rating.

lunes, 23 de febrero de 2026, 11:21 am ET1 min de lectura
FBIO--

Fortress Biotech: HC Wainwright Raises PT to $17, Reiterates Buy Rating.

Fortress Biotech: HC Wainwright Raises PT to $17, Reiterates Buy Rating.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios